Drug Shortage Report for MYLAN-BUDESONIDE AQ
| Report ID | 185423 |
| Drug Identification Number | 02230648 |
| Brand name | MYLAN-BUDESONIDE AQ |
| Common or Proper name | BUDESONIDE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 100MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 165 DOSE |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-03 |
| Estimated end date | 2025-04-17 |
| Actual end date | 2025-04-17 |
| Shortage status | Resolved |
| Updated date | 2025-04-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-04-23 | French | Compare |
| v9 | 2025-04-23 | English | Compare |
| v8 | 2025-04-14 | French | Compare |
| v7 | 2025-04-14 | English | Compare |
| v6 | 2023-12-12 | French | Compare |
| v5 | 2023-12-12 | English | Compare |
| v4 | 2023-08-16 | French | Compare |
| v3 | 2023-08-16 | English | Compare |
| v2 | 2023-02-23 | French | Compare |
| v1 | 2023-02-23 | English | Compare |
Showing 1 to 10 of 10